Health Protection Agency (HPA), on Monday, announced 125 additional cases of the new coronavirus, increasing confirmed coronavirus cases in Maldives to 24,908.
According to HPA, the 125 new cases include; 64 cases from the greater Male’ region, 46 cases from residential islands outside Male’, 14 cases from operational resorts, and one case from industrial islands.
Meanwhile, 127 additional coronavirus patients were confirmed to have made full recoveries over the last 24 hours, increasing total recoveries to 21,773.
With the new developments, Maldives now has 3,059 active cases.
There are 90 patients in hospitals.
3,237 samples (including repeated samples) have been tested for the new coronavirus over the last 24-hours.
With the 125 new infections this Monday, 1,237 people have tested positive over the last one-week period.
April 5: 125 cases
April 4: 132 cases
April 3: 103 cases
April 2: 169 cases
April 1: 300 cases
March 31: 241 cases
March 30: 167 cases
Maldives identified its first coronavirus case on March 7, and declared a state of public health emergency over the pandemic less than a week later on March 12.
While coronavirus cases had initially been restricted to resorts and safaris, and later quarantine facilities holding inbound travelers, Male’ City identified its first coronavirus case on April 15, prompting a city-wide lockdown.
The populous capital quickly emerged as the epicenter of the coronavirus outbreak in Maldives, contributing to the majority of total cases.
67 coronavirus patients have died from complications.
Maldives began mass vaccinations against the new coronavirus on February 1. HPA states 6,259 people were vaccinated on Monday. Of the 6,259 people, 4,243 received their first dose – 383 from greater Male’ region and 3,860 from the atolls, and 2,016 received their second dose – 1,903 from greater Male’ region and 113 from the atolls.
Total 251,139 people have now received their first dose under program, while 5,753 have received their second dose.
Maldives has received 200,000 doses of the Covishield developed AstraZeneca and Oxford from India, 100,000 Covishield doses procured from Serum Institute of India, and an additional 12,000 Covishield doses and 5,850 Pfizer doses through COVAX. The country has also received a donation of 200,000 doses of Sinopharm vaccine from China. The country has also ordered more doses of Covishield vaccine – 700,000 doses through an agreement with AstraZeneca and 100,000 more doses through an agreement with Serum Institute of India.